Market Overview

US Stock Futures Surge Ahead Of Earnings

US Stock Futures Surge Ahead Of Earnings

Pre-open movers

US stock futures traded higher in early pre-market trade, ahead of earnings from several companies. The NAHB housing market index for January will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average jumped 71 points to 17,503.00, while the Standard & Poor's 500 index futures rose 10.30 points to 2,023.20. Futures for the Nasdaq 100 index climbed 25 points to 4,159.00.

A Peek Into Global Markets

European markets were higher today, with the Spanish Ibex Index rising 1.47%, STOXX Europe 600 Index gaining 0.99% and German DAX 30 index rising 0.32%. French CAC 40 Index jumped 1.28% and London's FTSE 100 Index rose 0.68%.

In Asian markets, Japan's Nikkei Stock Average rose 2.07%, Hong Kong's Hang Seng Index climbed 0.90%, China's Shanghai Composite Index jumped 1.82% and India's Sensex jumped 1.85%.

Broker Recommendation
Analysts at JMP Securities downgraded Intel Corporation (NASDAQ: INTC) from Market Perform to Market Underperform. The price target for Intel is set to $30.

Intel's shares closed at $36.45 on Friday.

Breaking news

  • Celator Pharmaceuticals, Inc. (NASDAQ: CPXX) today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for CPX-351 (cytarabine:daunorubicin) for the treatment of elderly patients with secondary Acute Myeloid Leukemia (AML). To read the full news, click here.
  • Verastem, Inc. (NASDAQ: VSTM) today announced dosing of the first patient in a new clinical trial evaluating the combination of VS-5584, its dual mTORC1/2 and PI3K inhibitor, in combination with VS-6063, the Company's lead focal adhesion kinase (FAK) inhibitor, in patients with relapsed mesothelioma. To read the full news, click here.
  • Akorn, Inc. (NASDAQ: AKRX), today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on the Company's New Drug Application (NDA) for Phenylephrine Hydrochloride Ophthalmic Solution, USP, 2.5% and 10%. To read the full news, click here.
  • Baker Hughes Inc. (NYSE: BHI) reported a better-than-expected fourth-quarter profit. To read the full news, click here.

Posted-In: JMP Securities US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Related Articles (AKRX + BHI)

View Comments and Join the Discussion!

Compass Point Lowers Price Target On W.R. Berkley On Energy Investments

Credit Suisse Reiterates Rating, Lowers Price Target On FXCM On Cut 2015 Estimates